Authors' Reply: To the Letter to the Editor by Groheux et al

View More View Less
  • 1 University of California, San Francisco, California
Restricted access
  • 1.

    Ko H, Baghdadi Y, Love C, Sparano JA. Clinical Utility of 18F-FDG PET/CT in staging localized breast cancer before initiating preoperative systemic therapy. J Natl Compr Canc Netw 2020;18:12401246.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Hyland CJ, Varghese F, Yau C, et al. Use of 18F-FDG PET/CT as an initial staging procedure for stage II-III breast cancer: a multicenter value analysis. J Natl Compr Canc Netw 2020;18:15101517.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Caresia Aroztegui AP, Garcia Vicente AM, et al. 18F-FDG PET/CT in breast cancer: evidence-based recommendations in initial staging. Tumour Biol 2017;39:1010428317728285.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Han S, Choi JY. Impact of 18F-FDG PET, PET/CT, and PET/MRI on staging and management as an initial staging modality in breast cancer: a systematic review and meta-analysis. Clin Nucl Med 2021;46:271282.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Hong S, Li J, Wang S. 18FDG PET-CT for diagnosis of distant metastases in breast cancer patients. A meta-analysis. Surg Oncol 2013;22:139143.

  • 6.

    Sun Z, Yi YL, Liu Y, et al. Comparison of whole-body PET/PET-CT and conventional imaging procedures for distant metastasis staging in patients with breast cancer: a meta-analysis. Eur J Gynaecol Oncol 2015;36:672676.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Rong J, Wang S, Ding Q, et al. Comparison of 18 FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis. Surg Oncol 2013;22:8691.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Zhao FM, Solin LJ, Goldstein LJ, et al. A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: a trial of the ECOG-ACRIN Research Group (E2108) [abstract]. J Clin Oncol 2020;38(Suppl):Abstract LBA2.

    • Search Google Scholar
    • Export Citation
  • 9.

    Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 2019;393:20512058.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Gradisher WJ, Moran MS, Abraham J, et al. NCCN Clinical Practice Guidelines In Oncology: Breast Cancer. Version 3.2021. Accessed May 1, 2021. To view the most recent version, visit NCCN.org

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 74 74 35
PDF Downloads 53 53 22
EPUB Downloads 0 0 0